Endometriotic Mass After Hysterectomy in a 61 Year Old Post-menopausal Woman: A Case Report and Update

被引:3
作者
Mathey, Marie Pierre [1 ]
de Joliniere, Jean Bouquet [1 ]
Major, Attila [1 ]
Pugin, Francois [2 ]
Monnard, Etienne [3 ]
Fiche, M. [4 ]
Sandmeier, Daniel [4 ]
Khomsi, Fathi [1 ]
Feki, Anis [1 ]
机构
[1] Hop Cantonal Fribourg, Dept Chirurg Gynecol & Oncol, Fribourg, Switzerland
[2] Hop Cantonal Fribourg, Dept Chirurg Gen, Fribourg, Switzerland
[3] Hop Cantonal Fribourg, Dept Radiol & Radiol Intervent, Fribourg, Switzerland
[4] CHU Vaudois, Inst Pathol, Lausanne, Switzerland
来源
FRONTIERS IN SURGERY | 2019年 / 6卷
关键词
endometriosis; malignant transformation; mullerian adenofibroma; post-menopausal woman; hysterectomy; OVARIAN-CANCER; ASSOCIATION;
D O I
10.3389/fsurg.2019.00014
中图分类号
R61 [外科手术学];
学科分类号
摘要
Endometriosis is a common, hormone-dependent gynecologic disease. Undiagnosed in large proportion of women, managing therapies depend on the impact of quality of life and includes hormonal treatment and pelvic surgery. Less likely endometriosis can occur in post-menopausal women. Malignant transformation of endometriosis is a rare but well-described process, most of time occurring in the ovary, and justifies the practitioner not to underestimate this pathology. We present a case of a 61 year old woman with a symptomatic endometriotic pelvic mass, status post hysterectomy, with no history of endometriosis diagnosed beforehand.
引用
收藏
页数:6
相关论文
共 29 条
  • [1] Afors K, 2014, WOMENS HEALTH, V10, P431, DOI [10.2217/WHE.14.28, 10.2217/whe.14.28]
  • [2] Clinical diagnosis of endometriosis: a call to action
    Agarwal, Sanjay K.
    Chapron, Charles
    Giudice, Linda C.
    Laufer, Marc R.
    Leyland, Nicholas
    Missmer, Stacey A.
    Singh, Sukhbir S.
    Taylor, Hugh S.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (04) : 354.e1 - 354.e12
  • [3] Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma
    Arakawa, Noriaki
    Kobayashi, Hiroshi
    Yonemoto, Naohiro
    Masuishi, Yusuke
    Ino, Yoko
    Shigetomi, Hiroshi
    Furukawa, Naoto
    Ohtake, Norihisa
    Miyagi, Yohei
    Hirahara, Fumiki
    Hirano, Hisashi
    Miyagi, Etsuko
    [J]. PLOS ONE, 2016, 11 (10):
  • [4] Aromatase inhibitors: the next generation of therapeutics for endometriosis?
    Attar, Erkut
    Bulun, Serdar E.
    [J]. FERTILITY AND STERILITY, 2006, 85 (05) : 1307 - 1318
  • [5] Cancer risk after a hospital discharge diagnosis of endometriosis
    Brinton, LA
    Gridley, G
    Persson, I
    Baron, J
    Bergqvist, A
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (03) : 572 - 579
  • [6] Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast
    Bulun, SE
    Sharda, G
    Rink, J
    Sharma, S
    Simpson, ER
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) : 1273 - 1277
  • [7] Advances in sarcoma diagnostics and treatment
    Dancsok, Amanda R.
    Asleh-Aburaya, Karama
    Nielsen, Torsten O.
    [J]. ONCOTARGET, 2017, 8 (04) : 7068 - 7093
  • [8] ENDOMETRIOID CARCINOMA OF THE OVARY AND ENDOMETRIOSIS - THE ASSOCIATION IN POSTMENOPAUSAL WOMEN
    DEPRIEST, PD
    BANKS, ER
    POWELL, DE
    VANNAGELL, JR
    GALLION, HH
    PULS, LE
    HUNTER, JE
    KRYSCIO, RJ
    ROYALTY, MB
    [J]. GYNECOLOGIC ONCOLOGY, 1992, 47 (01) : 71 - 75
  • [9] Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor
    Fatemi, HM
    Al-Turki, HA
    Papanikolaou, EG
    Kosmas, L
    De Sutter, P
    Devroey, P
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2005, 11 (04) : 455 - 457
  • [10] Fletcher C. D. M. B. J., 2013, WHO Classification of Tumours of Soft Tissue and Bone, V5